ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jeffe

Jefferies Financial Group assumed coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Free Report) in a research note published on Tuesday, Marketbeat Ratings reports. The firm issued a buy rating and a $35.00 price target on the stock. Several other research firms have also issued reports on AVBP. The Goldman Sachs Group assumed coverage on […]

Related Keywords

Arrivent Biopharma , Jefferies Financial Group , Citigroup , Securities Exchange Commission , Arrivent Biopharma Inc , Orbimed Advisors Llc , Arrivent Biopharma Company Profile , Nasdaq , Goldman Sachs Group , Free Report , Marketbeat Ratings , Vent Biopharma Trading Down , Hillhouse Investment Managemen , Director Orbimed Advisors Llc , Exchange Commission , Get Free Report , Vent Biopharma , Arrivent Biopharma Daily , Nasdaq Avbp , Avbp , Medical , Initiated Coverage , Jefferies Financial Group Inc ,